For future access to innovative technologies/
novel therapeutic drug targets and collaboration
with early stage startup companies
- Ono Venture Investment makes a follow-on investment in Mediar Therapeutics.
(Mediar Therapeutics Announces $105 Million Financing to Advance Portfolio of First-in-Class Fibrosis Therapies)
- Ono Venture Investment Invests in Switch Therapeutics.
(Switch Therapeutics Launches with $52 Million to Advance First-of-its-Kind RNAi Technology)
- Ono Venture Investment Invests in Casma Therapeutics.
(Casma Therapeutics Raises $46.0 M in Series C Funding)